Immune reconstitution after high dose therapy with autologous blood stem cell support.

被引：0
|
作者：
Steingrimsdottir, H [1 ]
Gruber, A [1 ]
Bjorkholm, M [1 ]
Svensson, A [1 ]
Hansson, M [1 ]
机构：
[1] Karolinska Hosp, Dept Clin Immunol & Transfus Med, Dept Hematol & Infect Dis, S-17176 Stockholm, Sweden
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
451
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [41] Immune reconstitution after CD34+-enriched (Cellpro) autologous peripheral blood stem cell transplantation (SCT).
    Nachbaur, D
    Kropshofer, G
    Lätzer, C
    Glassl, H
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 1999, 23 : S230 - S230
  • [42] High-dose therapy and autologous blood stem cell transplantation in patients with follicular lymphoma
    Voso, MT
    Martin, S
    Abdallah, A
    Hohaus, S
    Ho, AD
    Haas, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S10 - S10
  • [43] High dose treatment with autologous stem cell support in an ordinary ward
    Rodjer, S
    Back, H
    Lindblad, R
    Nilsson, G
    Nilsson-Ehle, H
    Vilen, L
    BONE MARROW TRANSPLANTATION, 1998, 21 : S108 - S108
  • [44] Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support
    Johnsen, HE
    Bjorkstrand, B
    Carlson, K
    Gruber, A
    Blystad, A
    Fast, A
    Boesen, AM
    Bjorkholm, M
    Sallerfors, B
    Ruutu, T
    Carneskog, J
    Malm, A
    Geisler, C
    Lehtinen, M
    Schroder, H
    Brinch, L
    Remes, K
    Tidefelt, U
    Heilmann, C
    Hornsten, P
    Thorling, K
    Daugaard, G
    LEUKEMIA & LYMPHOMA, 1996, 24 (1-2) : 81 - 91
  • [45] COMPLETE RESPONSE AFTER HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL SUPPORT IS THE ONLY IMPORTANT PREDICTIVE FACTOR FOR SURVIVAL
    Lee, B.
    Shin, S. H.
    Min, C. K.
    Yhim, H. Y.
    Kwak, J. Y.
    Kim, J. A.
    HAEMATOLOGICA, 2012, 97 : 408 - 408
  • [46] High-dose therapy in high-grade non-Hodgkins lymphoma patients:: Comparison between unmanipulated peripheral blood progenitor cells and purged autologous bone marrow as stem cell support.
    Blystad, AK
    Kvaloy, S
    Delabie, J
    Torlakovic, E
    Holte, H
    Vålerhaugen, H
    Jakobsen, E
    Kvalheim, G
    BLOOD, 2000, 96 (11) : 183A - 183A
  • [47] High dose chemotherapy and autologous stem cell transplant without blood product support: "Bloodless transplantation".
    Jani, CR
    Ballen, KK
    Emmons, RVB
    Ford, PA
    Stewart, FM
    Quesenberry, PJ
    Otway, LA
    Levy, WS
    Becker, PS
    BLOOD, 2001, 98 (11) : 347B - 347B
  • [48] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL BLOOD STEM CELL SUPPORT IN CHILDREN WITH MALIGNANT DISEASES
    王建文
    唐锁勤
    杨光
    高晓宁
    冯晨
    于芳
    ChineseJournalofCancerResearch, 2005, (04) : 288 - 290
  • [49] Lenalidomide and T-cell homeostasis: tolerating immune reconstitution after autologous stem cell transplant
    Perry, Chava
    Polliack, Aaron
    LEUKEMIA & LYMPHOMA, 2014, 55 (08) : 1699 - 1700
  • [50] Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia
    Munshi, NC
    Barlogie, B
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 282 - 285
12345